Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome.
Taweesak WannachaleeAdina F TurcuRichard J AuchusPublished in: Clinical endocrinology (2018)
Mifepristone is effective in treating EAS for over 2 years, and survival was not different from that of patients treated with bilateral adrenalectomy. Aggressive concomitant therapy for hypokalaemia and hypertension is necessary.
Keyphrases